beta-lactams has been researched along with nitrocefin in 17 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (nitrocefin) | Trials (nitrocefin) | Recent Studies (post-2010) (nitrocefin) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 203 | 0 | 56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brems, DN; Kaiser, RE; Roychoudhury, S; Yeh, WK | 1 |
| Crowder, MW; McManus-Munoz, S | 1 |
| Kaminskaia, NV; Lippard, SJ; Spingler, B | 1 |
| Brown, RS; Montoya-Pelaez, PJ | 1 |
| Brown, RS; Gibson, GT; Montoya-Pelaez, PJ; Neverov, AA | 1 |
| Bethel, CR; Bonomo, RA; Helfand, MS; Hujer, AM | 1 |
| Flores, AR; Parsons, LM; Pavelka, MS | 1 |
| Black, MT; Claudon, M; Girard, AM; Levasseur, P; Miossec, C; Péchereau, MC; Stachyra, T | 1 |
| Blanchard, JS; Fan, F; Tremblay, LW | 1 |
| Breukink, E; Calvez, P; Contreras-Martel, C; Dib, M; Roper, DI; Zapun, A | 1 |
| Arthur, M; Edoo, Z; Hugonnet, JE | 1 |
| Keller, PM; Müller, DM; Rominski, A; Sander, P; Schulthess, B | 1 |
| Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y | 1 |
| Boehle, KE; Caraway, J; Carrell, CS; Henry, CS | 1 |
| Sharma, AK; Vats, P | 1 |
| Deng, X; Gao, Y; Niu, X; Sun, L; Wang, G; Wang, X; Yang, Y; Yu, Y | 1 |
| Ghosh, AS; Ghosh, SK; Kumar N, G; Kumar, G; Mallick, S; Pramanick, P | 1 |
17 other study(ies) available for beta-lactams and nitrocefin
| Article | Year |
|---|---|
Specific interaction between beta-lactams and soluble penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: development of a chromogenic assay.
Topics: Acylation; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cephalosporins; Chromogenic Compounds; Hexosyltransferases; Kinetics; Lactams; Mass Spectrometry; Methicillin Resistance; Muramoylpentapeptide Carboxypeptidase; Penicillin V; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Staphylococcus aureus; Thiazoles; Urea | 1996 |
Kinetic mechanism of metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cacodylic Acid; Cephalosporins; Hydrolysis; Indicators and Reagents; Kinetics; Lactams; Software; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Substrate Specificity; Xanthomonas | 1999 |
Intermediate in beta-lactam hydrolysis catalyzed by a dinuclear zinc(II) complex: relevance to the mechanism of metallo-beta-lactamase.
Topics: beta-Lactamases; beta-Lactams; Catalysis; Cephalosporins; Dimethyl Sulfoxide; Hydrogen-Ion Concentration; Hydrolysis; Metalloproteins; Solvents; Substrate Specificity; Water; Zinc | 2001 |
Methanolysis of nitrocefin catalyzed by one and two Zn(2+) ions. A simplified model for class B beta-lactamases.
Topics: Algorithms; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Binding Sites; Catalysis; Cations; Cephalosporins; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Molecular Structure; Substrate Specificity; Temperature; Titrimetry; Zinc | 2002 |
La3+-catalyzed methanolysis of N-aryl-beta-lactams and nitrocefin.
Topics: beta-Lactams; Catalysis; Cations; Cephalosporins; Hydrogen-Ion Concentration; Kinetics; Lanthanum; Methanol; Potentiometry | 2003 |
Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Escherichia coli; Escherichia coli Infections; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2004 |
Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Gene Deletion; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium smegmatis; Mycobacterium tuberculosis; Sequence Alignment | 2005 |
In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure | 2009 |
Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Cyclotrons; Doripenem; Ertapenem; Fourier Analysis; Hydrogen Bonding; Indicators and Reagents; Kinetics; Mass Spectrometry; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Protein Conformation | 2010 |
Substitutions in PBP2b from β-Lactam-resistant
Topics: Amino Acid Sequence; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Penicillin-Binding Proteins; Protein Denaturation; Recombinant Proteins; Sequence Homology, Amino Acid; Streptococcus pneumoniae | 2017 |
Reversible inactivation of a peptidoglycan transpeptidase by a β-lactam antibiotic mediated by β-lactam-ring recyclization in the enzyme active site.
Topics: Acylation; Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Catalytic Domain; Cephalosporins; Cyclization; Enterococcus faecium; Mass Spectrometry; Spectrophotometry | 2017 |
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalosporins; Drug Stability; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
Paper-Based Enzyme Competition Assay for Detecting Falsified β-Lactam Antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Counterfeit Drugs; Enzyme Assays; Equipment Design; Microfluidic Analytical Techniques; Paper; Tablets | 2018 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Molecular modeling and QM/MM calculation clarify the catalytic mechanism of β-lactamase N1.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalysis; Catalytic Domain; Cephalosporins; Humans; Hydrolysis; Kinetics; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Dynamics Simulation | 2019 |
Bio-surfactin stabilised silver nanoparticles exert inhibitory effect over New-Delhi metallo-beta-lactamases (NDMs) and the cells harbouring NDMs.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biofilms; Cephalosporins; Escherichia coli; Escherichia coli Infections; Metal Nanoparticles; Microbial Sensitivity Tests; Silver; Surface-Active Agents | 2019 |